For what it's worth, Bocxman's posts have been very useful in helping me to more fully understand this investment. His posts have been as even-handed as one could expect from a very knowledgable but enthusiastic investor. And the accusations about how he got the info about progress at Abbott seem much too severe. Obviously we are going to get different levels of disclosure depending on who answers the phone at the lab or in the office. Talk to the CEO/CFO, and you will get the party line. Talk to an employee, and you'll probably get more detailed information about how the tech is progressing. But expecting Bocxman to "name his sources" is plain silly-- those sources would hush up very quickly if he mentioned names.
We should all be grateful for all the hard work and time Bocxman has devoted to his many excellent and informative posts since last spring.
News 
Market Data 
Discover 
